Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of schedulPursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that meeting(s) with certain institutional investor(s) have been scheduled to discuss about the general business updates and the industry in which the Company operates as per the below details: Date of Meeting Particulars Type of Meetings Venue September 11, 2019 Non-Deal Roadshow One - on - One Singapore Please note that the above schedule may undergo change(s) due to exigencies on the part of the Investors / the Company and no unpublished price sensitive information shall be shared during the said meeting(s). We will keep the stock exchanges updated/informed in this regard. This is for your information and records please. e of institutional investors' meetings
10-09-2019
Bigul

From Apollo to Fortis, hospitals tap West Asia, Africa for new patients

 Foreign patients help hospitals increase occupancy, improve cash flow, build brand profile overseas, and serve as a hedge against currency volatility
01-09-2019
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Notice Of 23Rd Annual General Meeting Along With Annual Report

 Pursuant to the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the notice for convening 23rd Annual General Meeting along with Annual Report of Fortis Healthcare Limited, scheduled to be held on Thursday, September 26, 2019 at 12:00 Noon at National Institute of Pharmaceutical Education and Research Mohali, Sector 67, SAS Nagar, Mohali. This is for your information and records please.
30-08-2019
Bigul

Fortis Healthcare Ltd - 532843 - Sub: Disclosure(S) Under Regulation 30 - Closure Of SRL Middle East

 Dear Sir(s), Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that SRL Limited ('SRL'), a subsidiary of Fortis Healthcare Limited ('the Company'), informed that SRL Diagnostics FZ LLC, Dubai ('SRL FZ LLC'), a wholly owned subsidiary of SRL, has closed its board controlled subsidiary named as SRL Diagnostics Middle East LLC, Dubai ('SRL Middle East') through requesting cancellation of licence of SRL Middle East to relevant government authorities there. The detailed disclosure as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith as Annexure A. This is for your information and records please.
30-08-2019
Bigul

To nurse Fortis back to health, CEO plans to cut costs by 20%

 To negotiate pay with doctors, divest under-performing facilities, sell non-core assets and adopt task-shifting for nurses
20-08-2019
Bigul

Fortis Healthcare Ltd - 532843 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jupiter Asset Management Ltd
12-08-2019
Bigul

Mulling legal options to recover money from Malvinder Singh: Fortis CEO

 Auditor states that more related party transactions cannot be ruled out
07-08-2019
Bigul

Fortis Healthcare Ltd - 532843 - Outcome of Board Meeting

 This is with reference to our letter ref. no. FHL/SEC / 2019-20, dated August 6, 2019, captioned 'Outcome of the Board Meeting', we would like to submit that there was an inadvertent typographical errors w.r.t UDIN mentioned in 'Limited Review Report' issued by the Statutory Auditors attached with the outcome. A letter received from Statutory Auditor in this regard is attached herewith for your reference. This is for your information and records please.
07-08-2019
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Outcome of Board Meeting (AGM on Sept 26, 2019)

 Fortis Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 06, 2019, inter-alia, considered and approved the following: -- Convening of 23rd Annual General Meeting of the Company on September 26, 2019 at National Institute of Pharmaceutical Education and Research, Sector 67, SAS Nagar Mohali - Punjab, 160 062.
06-08-2019
Bigul

Fortis Healthcare Ltd - 532843 - Outcome of Board Meeting

 Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. August 6, 2019, inter-alia, considered and approved: - 1. Standalone and consolidated un-audited financial results of the Company for the quarter ended on June 30, 2019 along with limited review report thereon; 2. Convening of 23rd Annual General Meeting of the Company on Thursday, September 26, 2019 at National Institute of Pharmaceutical Education and Research, Sector 67, SAS Nagar Mohali- Punjab, 160062. Please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for quarter ended on June 30, 2019 and a copy of the press release and investor presentation being issued in this regard. The Board Meeting commenced at 0930 Hours and concluded at 1715 Hours.
06-08-2019
Next Page
Close

Let's Open Free Demat Account